Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBS-2 intranasal gel PK, safety, and initial PD study in women with HSDD or anorgasmia
NL-OMON34282Active, not recruiting
- Sponsor
- Trimel Pharmaceuticals
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of testosterone in hypoactive sexual desire disorder (HSDD) and anorgasmia, sponsored by Trimel Pharmaceuticals. Primary endpoints: Pharmacokinetic profile of TBS-2 administered BID, PK parameters and 2 more. Started Sep 2010; status: active, not recruiting.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)anorgasmia
Beyond the preview
Go deeper on NL-OMON34282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34282.